Association between the expression of somatostatin receptors and pathological features, prognosis in hepatocellular carcinoma

Association between the expression of somatostatin receptors and pathological features, prognosis in hepatocellular carcinoma

ObjectiveTo investigate the expression of somatostatin receptors (SSTRs) in hepatocellular carcinoma (HCC) tissue and its association with clinicopathological features and prognosis of HCC. MethodsHCC samples were collected from 80 patients who visited Third Hospital of PLA and Department of Hepatob...

Full description

Bibliographic Details
Main Author:	ZHU Feng
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2018-02-01
Series:	Linchuang Gandanbing Zazhi
Online Access:	http://www.lcgdbzz.org/qk_content.asp?id=8809

Similar Items

Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets
by: Daniel Kaemmerer, et al.
Published: (2017-12-01)

Correlation of PDK1 expression with clinicopathologic features and prognosis of hepatocellular carcinoma
by: Wang J, et al.
Published: (2016-09-01)

Expression of Mina53 and CBX8 in Hepatocellular Carcinoma and Their Correlation with Clinicopathological Features and Prognosis
by: YE Dongxue, et al.
Published: (2020-06-01)

Expression of Somatostatin Receptor 2 in Somatotropinoma Correlated with the Short-Term Efficacy of Somatostatin Analogues
by: Wenjuan Liu, et al.
Published: (2017-01-01)

Somatostatin receptor expression in parathyroid neoplasms
by: Sara Storvall, et al.
Published: (2019-08-01)

miR-370 expression in hepatocellular carcinoma tissue and its relationship with clinical pathology and prognosis
by: Ge Sun, et al.
Published: (2016-08-01)

Treatment of Advanced Hepatocellular Carcinoma with Somatostatin Analogues: A Review of the Literature
by: Hendrik Reynaert, et al.
Published: (2019-09-01)

Clinico-Radio-Pathological and Molecular Features of Hepatocellular Carcinomas with Keratin 19 Expression
by: Hyungjin Rhee, et al.
Published: (2020-10-01)

Elevated expression of neuropilin-2 associated with unfavorable prognosis in hepatocellular carcinoma
by: Dong X, et al.
Published: (2017-07-01)

Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis
by: Do In-Gu, et al.
Published: (2009-02-01)

Estrogens Modulate Somatostatin Receptors Expression and Synergize With the Somatostatin Analog Pasireotide in Prostate Cells
by: Valentina Rossi, et al.
Published: (2019-02-01)

Clinic pathological features and prognosis of metaplastic breast carcinoma
by: Ping Zhou, et al.
Published: (2019-08-01)

The androgen receptor expression and its activity have different relationships with prognosis in hepatocellular carcinoma
by: S. Acosta-Lopez, et al.
Published: (2020-12-01)

Somatostatin Octapeptide Inhibits Cell Invasion and Metastasis in Hepatocellular Carcinoma Through PEBP1
by: Chuan-Zhong Huang, et al.
Published: (2018-07-01)

Effects of terlipressin and somatostatin on liver function after major hepatectomy for hepatocellular carcinoma
by: Jiangwei Ye, et al.
Published: (2021-07-01)

Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
by: Kiyoshi Misawa, et al.
Published: (2015-01-01)

Internalisation of somatostatin agonists and somatostatin{sub2} receptor
by: Frawley, Lisa Antoinette
Published: (2002)

Versatile Functions of Somatostatin and Somatostatin Receptors in the Gastrointestinal System
by: Bilal Haider Shamsi, et al.
Published: (2021-03-01)

Expression of proteasome subunit beta type 4 in hepatocellular carcinoma and its association with prognosis
by: LU Qian
Published: (2020-02-01)

Expression of circular RNA FLI1 in patients with hepatocellular carcinoma and its association with prognosis
by: TANG Ling
Published: (2019-09-01)

Associations between CK1ε expression and hepatocellular carcinoma clinical pathological parameters in Taiwan
by: Shu-Hui Lin, et al.
Published: (2016)

High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma.
by: Shi-Hong Zhang, et al.
Published: (2013-01-01)

An Apoptotic Gene Signature for the Prognosis of Hepatocellular Carcinoma
by: Chen K, et al.
Published: (2021-03-01)

Studies on somatostatin receptors
by: Weightman, D. R.
Published: (1987)

Mammalian somatostatin receptors
by: Whitford, C.
Published: (1985)

Change in somatostatin receptor expression after vascular injury
by: Chen, Jerry
Published: (2009)

Imaging of Somatostatin Receptor Expression in Human Hepatoma Model
by: Chih-Hui Liu, et al.
Published: (2006)

Change in somatostatin receptor expression after vascular injury
by: Chen, Jerry
Published: (2009)

Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy
by: Matt Lechner, et al.
Published: (2021-01-01)

Expression features and prognostic significance of Yes-associated protein in hepatocellular carcinoma and cholangiocellular carcinoma
by: WANG Chun, et al.
Published: (2017-07-01)

Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma
by: Qiuyue Hu, et al.
Published: (2020-01-01)

High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma
by: Cao Yun, et al.
Published: (2011-01-01)

Decreased expression of zinc-alpha2-glycoprotein in hepatocellular carcinoma associates with poor prognosis
by: Huang Yan, et al.
Published: (2012-05-01)

Lost expression of ADAMTS5 protein associates with progression and poor prognosis of hepatocellular carcinoma
by: Li C, et al.
Published: (2015-03-01)

B4GALT5 high expression associated with poor prognosis of hepatocellular carcinoma
by: Han, Y., et al.
Published: (2022)

Elevated Expression of PDZD11 Is Associated With Poor Prognosis and Immune Infiltrates in Hepatocellular Carcinoma
by: Yao Chen, et al.
Published: (2021-05-01)

Somatostatin Receptors in Merkel-Cell Carcinoma: A Therapeutic Opportunity Using Somatostatin Analog Alone or in Association With Checkpoint Inhibitors Immunotherapy. A Case Report
by: Michele Guida, et al.
Published: (2020-07-01)

Increased expression of protease-activated receptors 2 indicates poor prognosis in HBV related hepatocellular carcinoma
by: Peng Chen, et al.
Published: (2019-11-01)

The correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomas
by: KyuHo Lee, et al.
Published: (2017-06-01)

Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological features
by: Osmar Damasceno Ribeiro, et al.